Spots Global Cancer Trial Database for ovarian epithelial cancer recurrent
Every month we try and update this database with for ovarian epithelial cancer recurrent cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection | NCT02260544 | Ovarian Epithel... | Doxorubicin Hyd... | 18 Years - 60 Years | Dr. Reddy's Laboratories Limited | |
| Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors | NCT02014337 | Breast Cancer Ovarian Epithel... Sarcoma Non-small Cell ... Carcinoma, Tran... Prostate Cancer Prostatic Neopl... | Mifepristone an... | 18 Years - | Corcept Therapeutics | |
| Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer | NCT01735071 | Ovarian Epithel... | bevacizumab and... bevacizumab, tr... | 18 Years - | Mario Negri Institute for Pharmacological Research | |
| Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Applied to Platinum-Resistant Recurrence of Ovarian Tumor | NCT02735928 | Ovarian Epithel... Platinum-resist... | Pressurized int... | 18 Years - 70 Years | Catholic University of the Sacred Heart | |
| Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection | NCT02260544 | Ovarian Epithel... | Doxorubicin Hyd... | 18 Years - 60 Years | Dr. Reddy's Laboratories Limited | |
| Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors | NCT02014337 | Breast Cancer Ovarian Epithel... Sarcoma Non-small Cell ... Carcinoma, Tran... Prostate Cancer Prostatic Neopl... | Mifepristone an... | 18 Years - | Corcept Therapeutics | |
| PankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer | NCT01899599 | Ovarian Epithel... Fallopian Tube ... Primary Periton... | PankoMab-GEX Placebo | 18 Years - | Glycotope GmbH | |
| Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Applied to Platinum-Resistant Recurrence of Ovarian Tumor | NCT02735928 | Ovarian Epithel... Platinum-resist... | Pressurized int... | 18 Years - 70 Years | Catholic University of the Sacred Heart | |
| Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)? | NCT01611766 | Ovarian Epithel... Fallopian Tube ... Primary Periton... | Secondary Cytor... Salvage Chemoth... | 18 Years - 80 Years | Shanghai Gynecologic Oncology Group | |
| Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer Treatment | NCT01376752 | Ovarian Epithel... | Maximal cytored... HIPEC | 18 Years - | UNICANCER | |
| PankoMab-GEX™ Versus Placebo as Maintenance Therapy in Advanced Ovarian Cancer | NCT01899599 | Ovarian Epithel... Fallopian Tube ... Primary Periton... | PankoMab-GEX Placebo | 18 Years - | Glycotope GmbH | |
| Retrospective Study to Analyze the Efficacy and Safety of Trabectedin and Pegylated Liposomal Doxorubicin (PLD ) in the Treatment of Patients With Platinum-sensitive Recurrent Ovarian Cancer (ROC), According to SmPC | NCT02394015 | Ovarian Epithel... | Trabectedin and... | - | Grupo Español de Investigación en Cáncer de Ovario |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
